Home › ARCA Biopharma To Present At The Rodman & Renshaw 17th Annual Global Investment Conference
 

Keywords :   


ARCA Biopharma To Present At The Rodman & Renshaw 17th Annual Global Investment Conference

2015-09-02 07:36:17| drugdiscoveryonline News Articles

ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, recently announced that its Chief Operating Officer, Thomas A. Keuer, will present at the Rodman & Renshaw 17th Annual Global Investment Conference, taking place September 8-10, 2015 in New York City

Tags: present global annual conference

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.06Diversified Labeling Solutions expands RFID capabilities
28.06Eastern North Pacific Tropical Weather Outlook
28.06Atlantic Tropical Weather Outlook
28.06Commitment leads to success in cattle marketing
28.06Kurz opens new facility in Germany
28.06Apex invests in Schepers laser engraving technology
28.06All4Labels opens first factory in Northeast Brazil
28.06WOW Conference Attracts Industry Leaders to Minneapolis
More »